These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
821 related items for PubMed ID: 24813429
1. Item-level assessment of the irritable bowel syndrome quality of life questionnaire in patients with diarrheal irritable bowel syndrome. Andrae DA, Covington PS, Patrick DL. Clin Ther; 2014 May; 36(5):663-79. PubMed ID: 24813429 [Abstract] [Full Text] [Related]
2. Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients. Andrae DA, Patrick DL, Drossman DA, Covington PS. Health Qual Life Outcomes; 2013 Dec 13; 11():208. PubMed ID: 24330412 [Abstract] [Full Text] [Related]
3. The impact of treatment with eluxadoline on health-related quality of life among adult patients with irritable bowel syndrome with diarrhea. Abel JL, Carson RT, Andrae DA. Qual Life Res; 2019 Feb 13; 28(2):369-377. PubMed ID: 30267294 [Abstract] [Full Text] [Related]
4. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study. Dove LS, Lembo A, Randall CW, Fogel R, Andrae D, Davenport JM, McIntyre G, Almenoff JS, Covington PS. Gastroenterology; 2013 Aug 13; 145(2):329-38.e1. PubMed ID: 23583433 [Abstract] [Full Text] [Related]
5. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation. Singh P, Staller K, Barshop K, Dai E, Newman J, Yoon S, Castel S, Kuo B. World J Gastroenterol; 2015 Jul 14; 21(26):8103-9. PubMed ID: 26185382 [Abstract] [Full Text] [Related]
6. Linguistic validation of the Irritable Bowel Syndrome-Quality of Life Questionnaire for Iranian patients. Gholamrezaei A, Zolfaghari B, Farajzadegan Z, Nemati K, Daghaghzadeh H, Tavakkoli H, Emami MH. Acta Med Iran; 2011 Jul 14; 49(6):390-5. PubMed ID: 21874644 [Abstract] [Full Text] [Related]
7. Quality of life in patients with irritable bowel syndrome. Mönnikes H. J Clin Gastroenterol; 2011 Aug 14; 45 Suppl():S98-101. PubMed ID: 21666428 [Abstract] [Full Text] [Related]
8. Intestinal symptoms and psychological factors jointly affect quality of life of patients with irritable bowel syndrome with diarrhea. Zhu L, Huang D, Shi L, Liang L, Xu T, Chang M, Chen W, Wu D, Zhang F, Fang X. Health Qual Life Outcomes; 2015 Apr 18; 13():49. PubMed ID: 25925746 [Abstract] [Full Text] [Related]
9. Improved work productivity and health-related quality of life in patients with irritable bowel syndrome with diarrhea receiving eluxadoline following inadequate response to loperamide. Brenner DM, Sayuk GS, Abel JL, Burslem K. J Manag Care Spec Pharm; 2021 Apr 18; 27(4):469-477. PubMed ID: 33769858 [Abstract] [Full Text] [Related]
10. Performance of the EQ-5D in patients with irritable bowel syndrome. Bushnell DM, Martin ML, Ricci JF, Bracco A. Value Health; 2006 Apr 18; 9(2):90-7. PubMed ID: 16626412 [Abstract] [Full Text] [Related]
11. The Comparison of WHOQOL-BREF with Disease Specific Heath Related Quality of Life Questionnaire in Irritable Bowel Syndrome. Jamali R, Biglari M. Acta Med Iran; 2015 Nov 18; 53(11):717-24. PubMed ID: 26786994 [Abstract] [Full Text] [Related]
12. Sex differences in the symptoms and psychological factors that influence quality of life in patients with irritable bowel syndrome. Tang YR, Yang WW, Wang YL, Lin L. Eur J Gastroenterol Hepatol; 2012 Jun 18; 24(6):702-7. PubMed ID: 22382707 [Abstract] [Full Text] [Related]
13. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Böhn L, Störsrud S, Törnblom H, Bengtsson U, Simrén M. Am J Gastroenterol; 2013 May 18; 108(5):634-41. PubMed ID: 23644955 [Abstract] [Full Text] [Related]
14. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study. Paré P, Gray J, Lam S, Balshaw R, Khorasheh S, Barbeau M, Kelly S, McBurney CR. Clin Ther; 2006 Oct 18; 28(10):1726-35; discussion 1710-1. PubMed ID: 17157129 [Abstract] [Full Text] [Related]
15. The Short Health Scale: A Simple, Valid, Reliable, and Responsive Way of Measuring Subjective Health in Patients With Irritable Bowel Syndrome. Krarup AL, Peterson E, Ringström G, Törnblom H, Hjortswang H, Simrén M. J Clin Gastroenterol; 2015 Aug 18; 49(7):565-70. PubMed ID: 25216385 [Abstract] [Full Text] [Related]
16. Effect of vitamin D on gastrointestinal symptoms and health-related quality of life in irritable bowel syndrome patients: a randomized double-blind clinical trial. Abbasnezhad A, Amani R, Hajiani E, Alavinejad P, Cheraghian B, Ghadiri A. Neurogastroenterol Motil; 2016 Oct 18; 28(10):1533-44. PubMed ID: 27154424 [Abstract] [Full Text] [Related]
17. Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS. Jerndal P, Ringström G, Agerforz P, Karpefors M, Akkermans LM, Bayati A, Simrén M. Neurogastroenterol Motil; 2010 Jun 18; 22(6):646-e179. PubMed ID: 20367800 [Abstract] [Full Text] [Related]
18. Double-blind placebo-controlled study of mesalamine in post-infective irritable bowel syndrome--a pilot study. Tuteja AK, Fang JC, Al-Suqi M, Stoddard GJ, Hale DC. Scand J Gastroenterol; 2012 Oct 18; 47(10):1159-64. PubMed ID: 22783919 [Abstract] [Full Text] [Related]
19. Alosetron versus traditional pharmacotherapy in clinical practice: effects on resource use, health-related quality of life, safety and symptom improvement in women with severe diarrhea-predominant irritable bowel syndrome. Olden KW, Chey WD, Shringarpure R, Paul Nicandro J, Chuang E, Earnest DL. Curr Med Res Opin; 2019 Mar 18; 35(3):461-472. PubMed ID: 30293448 [Abstract] [Full Text] [Related]
20. Therapeutic Effect of Chang'an I Recipe ( I ) on Irritable Bowel Syndrome with Diarrhea: A Multicenter Randomized Double-Blind Placebo-Controlled Clinical Trial. Tang XD, Lu B, Li ZH, Wei W, Meng LN, Li BS, Tang ZP, Gao R, Wang FY, Lu F, Bian LQ, Zhao YP, Wang P, Zhang YQ. Chin J Integr Med; 2018 Sep 18; 24(9):645-652. PubMed ID: 27487786 [Abstract] [Full Text] [Related] Page: [Next] [New Search]